Fernando Walder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fernando Walder has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Marcio Abrahao
Department of Otorhinolaryngology and Surgery of Head and Neck, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo 04023-062, SP, Brazil
6 shared publications - Onivaldo Cervantes
Department of Otorhinolaryngology and Surgery of Head and Neck, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo 04023-062, SP, Brazil
6 shared publications - Giulianno Molina de Melo
Universidade Federal de São Paulo, Escola Paulista de Medicina (UNIFESP/EPM), Department of Otorhinolaryngology and Surgery of Head and Neck, São Paulo, SP, Brazil; Hospital Beneficência Portuguesa de São Paulo, Department of Head and Neck Surgery, São Paulo, SP, Brazil
4 shared publications - Murilo Catafesta das Neves
Universidade Federal de São Paulo (UNIFESP), Department of Otorhinolaryngology and Head and Neck Surgery, São Paulo, SP, Brazil
4 shared publications - Alfio José Tincani
Department of Surgery, Head and Neck Surgery, School of Medical Sciences University of Campinas (UNICAMP) Campinas Brazil
2 shared publications - Antonio José Gonçalves
Faculdade de Ciencias Médicas da Santa Casa de São Paulo, Brazil
2 shared publications
Latest Publications
- Open Access
- 27 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 404
Prognostic Factors of Locally Advanced Cutaneous Squamous Cell Carcinoma in Head and Neck Region in Transplanted Patients
Background: Cutaneous squamous cell carcinoma (CSCC) is the second most common neoplasm in humans and the most frequent in Brazil (80% in the head and neck region, 20% mortality). Brazil is a world leader in organ transplants (more than 30,000 transplants in 2019). The risk of transplant patients (Tx) developing CSCC is 65–250 times higher, with deeper infiltration, advanced stage, higher local recurrence, occult metastases, and worse survival. Objective: To investigate the prognostic factors of locally advanced cutaneous squamous cell carcinoma (LACSCC) of the head and neck region in transplant patients. Methods: 16-year retrospective, single-center series of patients with LACSCC in the head and neck region who underwent surgical treatment. Clinical and Tx data, clinical/pathological stage, surgical treatment, parotid/regional and distant metastases, recurrence, and survival were analyzed. Results: 156 patients were included: 69.2% women, 65.3 years; mean primary size: 4.24 cm, 66% T3/T4 tumors, 71% grade 2/3 differentiation, 20.5% transplant recipients, follow-up: 33.6 months. The most affected regions were malar/nasal (28.8%) and auricular (19.2%). Surgeries included wide resection with reconstruction (58.9%), exenteration (14.1%), and temporalectomy (11.5%). Univariate analysis: Recurrence: immunosuppressor drugs (p = 0.009), transplanted (p = 0.006), compromised margin (p = 0.049); Mortality: immunosuppression (p = 0.028), total resection and reconstruction (p = 0.013), stage (8ed) III-IV (p < 0.001), compromised margin (p < 0.001), neck metastasis with extranodal extension (p = 0.018). Multivariate analysis: Recurrence: transplanted HR: 3.69 (p < 0.001), neck metastasis extranodal extension HR: 5.41 (p < 0.001), evolution to distant metastasis HR: 5.27 (p < 0.001); Mortality: neck metastasis extranodal extension HR: 1.94, (p = 0.032), compromised margins HR: 1.87 (p = 0.001). Main surgical procedures: temporalectomy HR: 2.83 (p = 0.007), major rhinectomy HR: 2.47 (p = 0.005); Worst overall survival: Tx compared to NonTx (p = 0.069); Worst survival with recurrence: Tx compared to NonTx (p = 0.005). Conclusions: The LACSCC and transplanted (immunosuppressed) group present low survival, worse prognosis; The formulation of specific guidelines to standardize treatment and predict outcomes on this population are strictly necessary.
- 27 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 404
Open AccessPrognostic Factors of Locally Advanced Cutaneous Squamous Cell Carcinoma in Head and Neck Region in Transplanted Patients
Background: Cutaneous squamous cell carcinoma (CSCC) is the second most common neoplasm in humans and the most frequent in Brazil (80% in the head and neck region, 20% mortality). Brazil is a world leader in organ transplants (more than 30,000 transplants in 2019). The risk of transplant patients (Tx) developing CSCC is 65–250 times higher, with deeper infiltration, advanced stage, higher local recurrence, occult metastases, and worse survival. Objective: To investigate the prognostic factors of locally advanced cutaneous squamous cell carcinoma (LACSCC) of the head and neck region in transplant patients. Methods: 16-year retrospective, single-center series of patients with LACSCC in the head and neck region who underwent surgical treatment. Clinical and Tx data, clinical/pathological stage, surgical treatment, parotid/regional and distant metastases, recurrence, and survival were analyzed. Results: 156 patients were included: 69.2% women, 65.3 years; mean primary size: 4.24 cm, 66% T3/T4 tumors, 71% grade 2/3 differentiation, 20.5% transplant recipients, follow-up: 33.6 months. The most affected regions were malar/nasal (28.8%) and auricular (19.2%). Surgeries included wide resection with reconstruction (58.9%), exenteration (14.1%), and temporalectomy (11.5%). Univariate analysis: Recurrence: immunosuppressor drugs (p = 0.009), transplanted (p = 0.006), compromised margin (p = 0.049); Mortality: immunosuppression (p = 0.028), total resection and reconstruction (p = 0.013), stage (8ed) III-IV (p < 0.001), compromised margin (p < 0.001), neck metastasis with extranodal extension (p = 0.018). Multivariate analysis: Recurrence: transplanted HR: 3.69 (p < 0.001), neck metastasis extranodal extension HR: 5.41 (p < 0.001), evolution to distant metastasis HR: 5.27 (p < 0.001); Mortality: neck metastasis extranodal extension HR: 1.94, (p = 0.032), compromised margins HR: 1.87 (p = 0.001). Main surgical procedures: temporalectomy HR: 2.83 (p = 0.007), major rhinectomy HR: 2.47 (p = 0.005); Worst overall survival: Tx compared to NonTx (p = 0.069); Worst survival with recurrence: Tx compared to NonTx (p = 0.005). Conclusions: The LACSCC and transplanted (immunosuppressed) group present low survival, worse prognosis; The formulation of specific guidelines to standardize treatment and predict outcomes on this population are strictly necessary.
- Open Access
- 10 December 2025
- Published by MDPI AG in Preprints.org
Prognostic Factors of Locally Advanced Skin Squamous Cell Carcinoma in Head and Neck Region in Transplanted Patients
Background: Squamous cell carcinoma of the skin (SCC) is the second most common neoplasm in humans and the most frequent in Brazil (80% in the head and neck region, 20% mortality). Brazil is a world leader in organ transplants (more than 30,000 transplants in 2019). The risk of transplant patients (Tx) developing SCC is 65-250 times higher, with deeper infiltration, advanced stage, higher local recurrence, occult metastases and worse survival. Objective: To investigate the prognostic factors of locally advanced cutaneous squamous cell carcinoma (LASCC) of the head and neck region in transplant patients. Methods:16-year retrospective, single-center series of patients with LASCC in the head and neck region who underwent surgical treatment. Were analyzed: clinical and Tx data, clinical/pathological stage, surgical treatment, parotid/regional and distant metastases, recurrence and survival. Results: 156 patients were included: 69.2% women, 65.3 years; mean primary size: 4.24 cm, 66% T3/T4 tumors, 71% grade 2/3 differentiation, 20.5% transplant recipients, follow-up: 33.6 months. Most affected regions: malar/nasal (28.8%), auricular (19.2%). Surgeries: wide resection with reconstruction (58.9%), exenteration (14.1%), temporalectomy (11.5%). Univariate analysis: Recurrence: immunosuppressor drugs (p=0.009), transplanted (p=0.006), compromised margin (p=0.049), Mortality: immunosuppression (p=0.028), Total Resection and reconstruction (p=0.013), Stage(8ed) III-IV (p<0.001), compromised margin (p<0.001), neck metastasis with extranodal extension (p=0.018). Multivariate analysis: Recurrence: Transplanted HR:3.69 (p<0.001), Neck metastasis extranodal extension HR:5.41 (p<0.001), Evolution to Distant metastasis HR:5.27 (p<0.001); Mortality: Neck metastasis extranodal extension HR:1.94, (p=0.032), Compromised Margins HR:1.87 (p=0.001), Main Surgical Procedures: Temporalectomy HR:2.83 (p=0.007); Major Rhinectomy HR:2.47 (p=0.005); Worst Overall Survival: Tx compared to NonTx (p=0.069), Worst Survival with Recurrence: Tx compared to NonTx (p=0.005). Conclusions: The LASCC and Transplanted (immunosuppressed) group present low survival, worse prognosis, high risk of recurrence and mortality outcome, formulation of specific guidelines to standardize treatment and predict outcomes in this population are strictly necessary.
- 10 December 2025
- Published by MDPI AG in Preprints.org
Open AccessPrognostic Factors of Locally Advanced Skin Squamous Cell Carcinoma in Head and Neck Region in Transplanted Patients
Background: Squamous cell carcinoma of the skin (SCC) is the second most common neoplasm in humans and the most frequent in Brazil (80% in the head and neck region, 20% mortality). Brazil is a world leader in organ transplants (more than 30,000 transplants in 2019). The risk of transplant patients (Tx) developing SCC is 65-250 times higher, with deeper infiltration, advanced stage, higher local recurrence, occult metastases and worse survival. Objective: To investigate the prognostic factors of locally advanced cutaneous squamous cell carcinoma (LASCC) of the head and neck region in transplant patients. Methods:16-year retrospective, single-center series of patients with LASCC in the head and neck region who underwent surgical treatment. Were analyzed: clinical and Tx data, clinical/pathological stage, surgical treatment, parotid/regional and distant metastases, recurrence and survival. Results: 156 patients were included: 69.2% women, 65.3 years; mean primary size: 4.24 cm, 66% T3/T4 tumors, 71% grade 2/3 differentiation, 20.5% transplant recipients, follow-up: 33.6 months. Most affected regions: malar/nasal (28.8%), auricular (19.2%). Surgeries: wide resection with reconstruction (58.9%), exenteration (14.1%), temporalectomy (11.5%). Univariate analysis: Recurrence: immunosuppressor drugs (p=0.009), transplanted (p=0.006), compromised margin (p=0.049), Mortality: immunosuppression (p=0.028), Total Resection and reconstruction (p=0.013), Stage(8ed) III-IV (p<0.001), compromised margin (p<0.001), neck metastasis with extranodal extension (p=0.018). Multivariate analysis: Recurrence: Transplanted HR:3.69 (p<0.001), Neck metastasis extranodal extension HR:5.41 (p<0.001), Evolution to Distant metastasis HR:5.27 (p<0.001); Mortality: Neck metastasis extranodal extension HR:1.94, (p=0.032), Compromised Margins HR:1.87 (p=0.001), Main Surgical Procedures: Temporalectomy HR:2.83 (p=0.007); Major Rhinectomy HR:2.47 (p=0.005); Worst Overall Survival: Tx compared to NonTx (p=0.069), Worst Survival with Recurrence: Tx compared to NonTx (p=0.005). Conclusions: The LASCC and Transplanted (immunosuppressed) group present low survival, worse prognosis, high risk of recurrence and mortality outcome, formulation of specific guidelines to standardize treatment and predict outcomes in this population are strictly necessary.
- Open Access
- 29 March 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (4) , rjaf197
Microwave ablation of thyroid nodules and metastatic thyroid cervical lymph nodes: the first case series from Ecuador
Microwave ablation (MWA) has emerged as a minimally invasive technique, transforming the therapeutic landscape for benign thyroid nodules (BTN), papillary thyroid microcarcinoma (PTMC), and cervical lymph node metastasis (CLNM). This study aims to present the first experience in Ecuador using MWA. We included adults undergoing MWA for BTN, PTMC, and CLNM between September 2022 and April 2023. Descriptive statistics and the Wilcoxon signed-rank test were used to compare some pre- and post-intervention outcomes. Fourteen patients (11 BTN, one PMTC, and two CLNM) were included. Most were female (86%; mean age 48.92 years) and euthyroid (73%). Most nodules were solid (92%). The volume reduction (VR) of BTN was 98% at 12-months. The PTMC nodule disappeared and the CLNM mean volume reduced to 0.03 at 12 months. These findings highlight MWA as a potential treatment for various thyroid pathologies, warranting further exploration and validation in larger cohorts.
- 29 March 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (4) , rjaf197
Open AccessMicrowave ablation of thyroid nodules and metastatic thyroid cervical lymph nodes: the first case series from Ecuador
Microwave ablation (MWA) has emerged as a minimally invasive technique, transforming the therapeutic landscape for benign thyroid nodules (BTN), papillary thyroid microcarcinoma (PTMC), and cervical lymph node metastasis (CLNM). This study aims to present the first experience in Ecuador using MWA. We included adults undergoing MWA for BTN, PTMC, and CLNM between September 2022 and April 2023. Descriptive statistics and the Wilcoxon signed-rank test were used to compare some pre- and post-intervention outcomes. Fourteen patients (11 BTN, one PMTC, and two CLNM) were included. Most were female (86%; mean age 48.92 years) and euthyroid (73%). Most nodules were solid (92%). The volume reduction (VR) of BTN was 98% at 12-months. The PTMC nodule disappeared and the CLNM mean volume reduced to 0.03 at 12 months. These findings highlight MWA as a potential treatment for various thyroid pathologies, warranting further exploration and validation in larger cohorts.
- 1 November 2022
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 88 (6) , 982-989
Análise da situação do tratamento das doenças benignas da tireoide – Um problema de saúde pública agravado pela pandemia de Covid‐19
- 1 November 2022
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology (Versão em Português)
- Vol. 88 (6) , 982-989
Análise da situação do tratamento das doenças benignas da tireoide – Um problema de saúde pública agravado pela pandemia de Covid‐19
- Open Access
- 24 November 2021
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 65 (6) , 860-861
Response to the letter: Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA): Pioneers's Point of View
Dear Editors and Colleagues We have examined with attention the comments of the letter to the Editor in regards to our recently published article (), and want to thank its authors for their interest in our work. […] Response to the letter: Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA): Pioneers’s Point of View Dear Editors and Colleagues We have examined with attention the comments of the letter to the Editor in regards to our recently published article (), and want to thank its authors for their interest in our work. […] Response to the letter: Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA): Pioneers’s Point of View
- 24 November 2021
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 65 (6) , 860-861
Open AccessResponse to the letter: Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA): Pioneers's Point of View
Dear Editors and Colleagues We have examined with attention the comments of the letter to the Editor in regards to our recently published article (), and want to thank its authors for their interest in our work. […] Response to the letter: Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA): Pioneers’s Point of View Dear Editors and Colleagues We have examined with attention the comments of the letter to the Editor in regards to our recently published article (), and want to thank its authors for their interest in our work. […] Response to the letter: Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA): Pioneers’s Point of View
- Open Access
- 23 October 2021
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 88 (6) , 982-989
Analysis of the status of treatment of benign thyroid diseases — a public health problem aggravated in the COVID-19 pandemic era
- 23 October 2021
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 88 (6) , 982-989
Open AccessAnalysis of the status of treatment of benign thyroid diseases — a public health problem aggravated in the COVID-19 pandemic era
- Open Access
- 29 June 2021
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 65 (3) , 396-399
Transoral thyroidectomy: A reflexive opinion on the technique
When analyzing the literature published on thyroidectomy using a “timeline” we can observe that we have notoriously progressed from a procedure that was almost prohibited in the mid-nineteenth century due to complications to a point where it is considered safe, resolutive, and highly efficient. This progress is especially due to the advances in surgical techniques. Theodore Kocher (Nobel Prize in 1909 for his contribution to thyroidectomies) flawlessly described the anatomical basis for the success of this surgical technique 130 years ago. Besides this, advances in anesthetic procedures, surgical materials, and medications were fundamental to intraoperative and postoperative advances and patient management. With time, the knowledge on the different thyroid diseases has exponentially increased and serves as indicators for the extension of treatment and surgical procedures, all efforts should be directed to apply them into clinical practice (1 1. Cernea CR, Brandão LG, Hojaij FC, De Carlucci D, Montenegro FL, Plopper C, et al. How to minimize complications in thyroid surgery? Auris Nasus Larynx. 2010;37(1):1-5. ).
- 29 June 2021
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 65 (3) , 396-399
Open AccessTransoral thyroidectomy: A reflexive opinion on the technique
When analyzing the literature published on thyroidectomy using a “timeline” we can observe that we have notoriously progressed from a procedure that was almost prohibited in the mid-nineteenth century due to complications to a point where it is considered safe, resolutive, and highly efficient. This progress is especially due to the advances in surgical techniques. Theodore Kocher (Nobel Prize in 1909 for his contribution to thyroidectomies) flawlessly described the anatomical basis for the success of this surgical technique 130 years ago. Besides this, advances in anesthetic procedures, surgical materials, and medications were fundamental to intraoperative and postoperative advances and patient management. With time, the knowledge on the different thyroid diseases has exponentially increased and serves as indicators for the extension of treatment and surgical procedures, all efforts should be directed to apply them into clinical practice (1 1. Cernea CR, Brandão LG, Hojaij FC, De Carlucci D, Montenegro FL, Plopper C, et al. How to minimize complications in thyroid surgery? Auris Nasus Larynx. 2010;37(1):1-5. ).